LXRX — Lexicon Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $247.18m
- $109.52m
- $31.08m
- 37
- 15
- 44
- 23
Annual cashflow statement for Lexicon Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -58.6 | -87.8 | -102 | -177 | -200 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | -118 | 10.7 | 12.3 | 12 | 6.85 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 31.1 | -10.2 | 0.402 | 2.66 | 14.2 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -143 | -87 | -88.9 | -162 | -179 |
| Capital Expenditures | -0.087 | -1.22 | -1.33 | -0.47 | -1.03 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 381 | 3.33 | -69.8 | -49.5 | -14.3 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 381 | 2.11 | -71.1 | -49.9 | -15.4 |
| Financing Cash Flow Items | — | — | — | — | -1.31 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -148 | 22.7 | 142 | 188 | 238 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 90.2 | -62.2 | -17.7 | -23.9 | 44.2 |